These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2983253)

  • 1. Effect of the angiotensin converting enzyme inhibitor, captopril (SQ14,225), on orthostatic sodium and water retention in patients with idiopathic edema.
    Suzuki H; Fujimaki M; Nakane H; Saito I; Takeshita E; Saruta T
    Nephron; 1985; 39(3):244-9. PubMed ID: 2983253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal adaptation to sodium deprivation. Effect of captopril in the rat.
    Mimran A; Jover B; Casellas D
    Am J Med; 1984 May; 76(5B):14-21. PubMed ID: 6328982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ; Tree M; Casals-Stenzel J
    Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with captopril of idiopathic edemas (author's transl)].
    Mimran A
    Nouv Presse Med; 1981 Apr; 10(19):1594-5. PubMed ID: 7025852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic response of idiopathic edema to captopril.
    Docci D; Turci F; Salvi G
    Nephron; 1983; 34(3):198-200. PubMed ID: 6348569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects].
    Seto S; Kaku T; Shinagawa T; Matsumoto Y; Doi Y; Tasaki S; Murayama M; Aoi W; Kuramochi M; Hashiba K
    Nihon Naika Gakkai Zasshi; 1980 Nov; 69(11):1439-46. PubMed ID: 7017040
    [No Abstract]   [Full Text] [Related]  

  • 17. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
    Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A
    J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glomerular filtration rate and renal plasma flow in cirrhotic rats during converting enzyme inhibition.
    Ibarra FR; Galcerán T; Oddo E; Arrizurieta E
    Ren Fail; 1998 Jan; 20(1):65-74. PubMed ID: 9509561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
    Thomsen OO; Danielsen H; Sørensen SS; Pedersen EB
    Eur J Clin Pharmacol; 1986; 30(1):1-6. PubMed ID: 3519238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.